Top Midday Decliners

MT Newswires Live

Aug 21

James Hardie Industries (JHX) shares slumped 36% after the company reported late Tuesday a year-over-year decline in fiscal Q1 adjusted earnings and sales.

Truist cuts its price target on the stock to $25 from $35 while keeping its buy rating.

More than 48.2 million shares traded intraday, compared with a daily average of about 6.31 million.

EnVVeno Medical (NVNO) said Wednesday it received a not-approvable letter from the US Food and Drug Administration in response to its premarket approval application for VenoValve, a surgical replacement venous valve to treat deep chronic venous insufficiency.

Shares plunged 71%, with intraday trading volume catapulting to over 12.2 million from a daily average of about 141,000.

Calidi Biotherapeutics (CLDI) said it has priced an underwritten public offering to raise $6 million.

Shares sank 43%, with trading volume of over 2.44 million against a daily average of about 1.48 million.

Price: 1.21, Change: -2.99, Percent Change: -71.24

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2561486890"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2561486890\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2561486890?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-21 02:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2561486890","market":"us","top_or_hot":-1,"title":"Top Midday Decliners","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/JHIUF\">James Hardie</a> Industries (JHX) shares slumped 36% after the company reported late Tuesday a year-over-year decline in fiscal Q1 adjusted earnings and sales.</p><p>Truist cuts its price target on the stock to $25 from $35 while keeping its buy rating.</p><p>More than 48.2 million shares traded intraday, compared with a daily average of about 6.31 million.</p><p>EnVVeno Medical (NVNO) said Wednesday it received a not-approvable letter from the US Food and Drug Administration in response to its premarket approval application for VenoValve, a surgical replacement venous valve to treat deep chronic venous insufficiency.</p><p>Shares plunged 71%, with intraday trading volume catapulting to over 12.2 million from a daily average of about 141,000.</p><p><a href=\"https://laohu8.com/S/CLDI\">Calidi Biotherapeutics</a> (CLDI) said it has priced an underwritten public offering to raise $6 million.</p><p>Shares sank 43%, with trading volume of over 2.44 million against a daily average of about 1.48 million.</p><p>Price: 1.21, Change: -2.99, Percent Change: -71.24</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Midday Decliners</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Midday Decliners\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-08-21 02:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/JHIUF\">James Hardie</a> Industries (JHX) shares slumped 36% after the company reported late Tuesday a year-over-year decline in fiscal Q1 adjusted earnings and sales.</p><p>Truist cuts its price target on the stock to $25 from $35 while keeping its buy rating.</p><p>More than 48.2 million shares traded intraday, compared with a daily average of about 6.31 million.</p><p>EnVVeno Medical (NVNO) said Wednesday it received a not-approvable letter from the US Food and Drug Administration in response to its premarket approval application for VenoValve, a surgical replacement venous valve to treat deep chronic venous insufficiency.</p><p>Shares plunged 71%, with intraday trading volume catapulting to over 12.2 million from a daily average of about 141,000.</p><p><a href=\"https://laohu8.com/S/CLDI\">Calidi Biotherapeutics</a> (CLDI) said it has priced an underwritten public offering to raise $6 million.</p><p>Shares sank 43%, with trading volume of over 2.44 million against a daily average of about 1.48 million.</p><p>Price: 1.21, Change: -2.99, Percent Change: -71.24</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2561486890","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2561486890","pubTimestamp":1755714967,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"James Hardie Industries (JHX) shares slumped 36% after the company reported late Tuesday a year-over-year decline in fiscal Q1 adjusted earnings and sales.Truist cuts its price target on the stock to ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","BK4082":"医疗保健设备","JHX":"詹姆斯哈迪","JHX.AU":"JAMES HARDIE INDUSTRIES-CDI","NVNO":"enVVeno Medical Corp.","CLDI":"CALIDI BIOTHERAPEUTICS INC","BK7044":"建筑材料","BK4011":"建筑材料"},"translate_title":"午盘跌幅最大的股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CLDI":0.9,"NVNO":0.9,"JHX":0.9,"JHX.AU":1},"content_text":"James Hardie Industries (JHX) shares slumped 36% after the company reported late Tuesday a year-over-year decline in fiscal Q1 adjusted earnings and sales.Truist cuts its price target on the stock to $25 from $35 while keeping its buy rating.More than 48.2 million shares traded intraday, compared with a daily average of about 6.31 million.EnVVeno Medical (NVNO) said Wednesday it received a not-approvable letter from the US Food and Drug Administration in response to its premarket approval application for VenoValve, a surgical replacement venous valve to treat deep chronic venous insufficiency.Shares plunged 71%, with intraday trading volume catapulting to over 12.2 million from a daily average of about 141,000.Calidi Biotherapeutics (CLDI) said it has priced an underwritten public offering to raise $6 million.Shares sank 43%, with trading volume of over 2.44 million against a daily average of about 1.48 million.Price: 1.21, Change: -2.99, Percent Change: -71.24","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}